FDA & EMA approvals for rare genetic diseases are fast and require clinical studies with small number of patients Ramat Gan, Israel, March ...

An openly available generative AI tool can interpret millions of cells in human tissues in hours, revealing new insights and allowing researchers and clinicians to ask questions about conditions such ...

"When we announced one million profiles analyzed in 2022, it was a landmark moment in the evolution of data-driven medicine," said Jurgi Camblong, PhD., Chief Executive Officer and Co-founder of ...

Precision Medicine Online's 2024 survey shows biomarker test expansion but low clinical trial enrollment and long wait times for advanced therapies.

Small nucleolar RNAs (snoRNAs) are non-coding RNA molecules whose role in gene regulation and association with certain ...

The Association of Cancer Care Centers (ACCC), in collaboration with Eli Lilly and Company, is pleased to announce the seven recipients of the "Improving the Precision Oncology Care Pathway" Request ...

The OriGen Health Research Center will mine a massive biobank of genetic, clinical and epidemiological information to develop ...

DIET plays a vital role in reducing cancer risk. High red meat intake has been linked to increased risk of bowel cancer, ...

A first-of-its-kind artificial intelligence (AI)-based neural network can rapidly analyze and interpret millions of cells from a patient sample, predicting molecular changes in the tissue.

Explore the unexpected factors that may influence brain tumor risk and learn practical steps to protect your health and well-being.